drugset / Trial / NCT03909594
Bubiket Study: Ultrasound Guided Fascia Iliaca Nerve Block With Bupivacaine and Adjuvant Ketamine vs. Bupivacaine Alone
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The project is meant to evaluate the effect of a combination of medications (Bupivacaine + Ketamine) used in an ultra-sound guided nerve block for patients presenting to the Emergency Department (ED) with hip and/or femur fractures. The goal is to see whether the combination of these two medications will result in greater and longer-lasting pain relief, longer-lasting motor and sensory block and overall less need for opioid rescue analgesia.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Outcome
Outcome not reported
Stopped: “The COVID Pandemic delayed start of study and currently the investigators are not interested in conducting the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 0.5 % | Other |
| Subject | Bupivacaine | Other / unclassified | 2.5 mg/kg | Other |
| Subject | Ketamine | Small molecule | 2 mg/kg | Other |
| Subject | Ketamine | Small molecule | 50 mg/ml | Other |
Indications
No indication recorded.